LGN Legence Corp.
Legence Corp. provides engineering, installation, and maintenance services for mission-critical systems in buildings in the United States. The company operates through two segments, Engineering & Consulting, and Installation & Maintenance. The Engineering & Consulting segment designs HVAC and other MEP systems for buildings, develops strategies to help reduce energy usage and make buildings more sustainable and provides program and project management services for client's installation and retrofit projects. This segment also offers engineering & design and program and project management services. The Installation & Maintenance segment fabricates and installs HVAC systems, process piping and other MEP systems in new and existing industrial, commercial and institutional buildings and provides ongoing preventative and corrective maintenance services, emergency repair, and break-fix services, as well as facility energy analysis, automation, optimization, and system certification and testing. It serves data centers, technology, life sciences, healthcare, education, mixed-use, state and local government, and other markets. The company was founded in 1914 and is based in San Jose, California.…
Industry Peers
Engineering & ConstructionKey Statistics
About Legence (NASDAQ: LGN)
›
Legence (NASDAQ: LGN) is listed on Nasdaq, where its shares trade in USD. It belongs to the Engineering & Construction industry, part of the Industrials sector, and reports about 7,000 employees.
The shares were at 35.09 USD on 19 November 2026, down 21.9% over 52 weeks. Its 52-week range is 23.90 USD to 107.24 USD: the price is 67.3% below the high and 46.8% above the low.
At a market capitalisation of 5.44B USD, it trades at 90.0 times trailing earnings and 12.2 times forward earnings. The median trailing P/E of its 19 largest Engineering & Construction peers is 24.1, a premium of 274% for LGN.
Legence reports return on equity of -8.5%, an operating margin of 5.6% and revenue up 85.1% year over year.
Its debt exceeds its cash by 846.13M USD, a debt-to-equity ratio of 1.65. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 17 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 72.18 USD is 105.7% above the current price. The next earnings report is expected on 29 March 2027.